Menu
Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 12
Review
SGLT-2 inhibitors as promising therapeutics for non-alcoholic fatty liver disease: pathophysiology, clinical outcomes, and future directions
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 11,719 | Dovepress* | 9,312+ | 1,906 | 11,218 | |
| PubMed Central* | 2,407 | 712 | 3,119 | ||
| Totals | 11,719 | 2,618 | 14,337 | ||
| *Since 3 July 2019 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 1 |
View citations on PubMed Central and Google Scholar